HealthCap — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

InCarda Therapeuticsincardatherapeutics.com inOct 2017 · $30M

Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.

BiotechDigital HealthMedical DevicesBrisbane, US

Carlos A. Schuler(Executive Officer, Director)in John S. Patton(Executive Officer, Director)inRangachari Narasimhan(Executive Officer, Director)Grace Colon(Executive Officer, Director)inMiller Samantha(Executive Officer)

BoardMcCarthy Reenie(Director)

Board seat Johan Christenson· per SEC Form D

Co-investorsAsset Management Company Sofinnova Ventures Deerfield Management Company

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.